Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Hovione
Sort By
Newest First
1 / 2
1 / 2
Strategic Partnership
Hovione and Laxxon Medical Establish an Agreement for the cGMP Production of 3D Screen Printed Pharmaceutical Applications
Hovione
PR-M03-23-06
March 22, 2023
CDMO Leadership Award
Hovione Receives the 2023 CDMO Leadership Award in All Six Categories and Is Champion in Compatibility and Expertise
Hovione
PR-M03-23-01
March 08, 2023
Continuous Tableting
Hovione and GEA Announce a Strategic Collaboration to Advance Continuous Tableting
Hovione
PR-M12-22-02-176
December 14, 2022
Global License Agreement
Hovione and JIXING Announce an Exclusive Global License Agreement for Ophthalmology Program
Hovione
PR-M05-22-04
May 09, 2022
Business Leadership
Jean-Luc Herbeaux to Become Hovione CEO
Hovione
PR-M02-22-23
February 25, 2022
Strategic Partnership
Hovione and Zerion Pharma Announce a Strategic Partnership to Market the Dispersome® Technology Platform
Hovione
PR-M02-22-19
February 22, 2022
Strategic Collaboration
Hovione and iBET Announce Strategic Collaboration
Hovione
PR-M05-21-020
May 27, 2021
Ophthalmology
Hovione Completes its Phase II Clinical Trial of the First Minocycline Ophthalmic Showing Promise in Dry Eye Disease Associated with Inflamed Meibomian Gland Dysfunction
Hovione
PR-M03-21-003
March 17, 2021
Screening Service
Hovione Launches ASD-HIPROS the Most Advanced Screening Service for Optimal Spray Dried Dispersions Formulation
Hovione
PR-M11-20-033
January 12, 2021
COVID-19
Hovione Announces Partnership to Support Manufacturing of Antiviral Veklury for COVID-19
Hovione
PR-M09-20-26
September 23, 2020
Drug Development
Bilim Pharmaceuticals, H&T Presspart and Hovione Technology Unveil Collaboration for New Asthma Product: Ventofor Combi Fix Delivered by PowdAir Plus
Hovione Technology
PR-M09-20-NI-02
September 01, 2020
Leadership
Hovione Announces the Appointment of Jean-Luc Herbeaux as Chief Operating Officer
Hovione
PR-M05-20-NI-006
May 04, 2020
Phase II
Hovione Announces Successful End-of-Phase 2 Meeting with the FDA and Outlines Phase 3 Program for Minocycline Topical Gel
Hovione
PR-M09-19-NI-047
September 20, 2019
Collaboration
Hovione Technology Signs Collaboration Agreement with Kiel University
Hovione Technology
PR-M09-19-NI-012
September 05, 2019
Formulation
Developing and Characterizing DPI Formulations for Biologics
Eunice Costa; Constança Cacela
Hovione
PAP-Q1-2019-CL-002
April 12, 2019
Finance
Hovione Issues $50 Million Bond
Hovione
PR-M01-19-NI-081
January 28, 2019
Formulation
The Coming of Age of Amorphous Solid Dispersions
Márcio Temtem, Ph.D.
Hovione
PAP-Q4-18-CL-004
October 26, 2018
Expanded Capacity
Hovione Reports on Recent Capacity Expansion and Future Plans to Support Growth
Hovione
PR-M03-18-NI-081
March 22, 2018
Regulatory
Compliance at Hovione, Annual Inspection Review
Hovione
PR-M03-18-NI-037
March 12, 2018
Inhalation
Hovione strengthens Inhalation Services portfolio
Hovione
PR-M01-18-NI-084
January 24, 2018
